dinitrobenzene s-glutathione RCSB PDB Glutathione S‐transferase (GST) activities toward...
Description
Top panels illustrate mechanisms of action: atropine (2.1 mg) competitively antagonizes acetylcholine at muscarinic receptors to reverse cholinergic effects (e.g., bronchorrhea, bronchospasm, bradycardia), while pralidoxime (2PAM, 600 mg) reactivates acetylcholinesterase by cleaving the nerve agentenzyme bond prior to irreversible aging. Middle panels depict the dualchamber autoinjector design, which contains atropine and pralidoxime in separate compartments and delivers both drugs sequentially via a springloaded intramuscular mechanism from a single needle
Data Availability Statement The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
WNT10B mutations in human obesity
Does Epitalon cause weight loss
